Estrogen treatment increases mitochondrial mass, the DNA-binding activity of NRF1, a regulator of TFAM, and the level of TFAM, and TFAM shRNA inhibits colony formation in E2-treated breast cancer cells. Here, NRF1 is linked to breast carcinoma.